About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Novel Device to Assess Endotracheal Tube Migration

NCT01697215·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

The Cleveland Clinic

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subjects will be eligible for inclusion in the study if they meet ALL of the following criteria:
Oral or nasal endotracheal intubation, anticipated to last at least 48 hours
Adults that require ETT internal diameter sizes of 6.5 - 9.0 mm
Subject must be at least 18 years old (no upper age limitation)
English speaking patients/decision makers.

You may not be if

Subjects ventilated through a tracheostomy
Subjects under 18 years of age

The record

StatusCompleted

PhaseNo phase

Taking part42

StartedApr 2012

UpdatedMay 14, 2025

Conditions

Mechanically Ventilated Patients Admitted to a MICU

Where1

Cleveland Clinic
Cleveland, Ohio, United States

Clareo Health | Novel Device to Assess Endotracheal Tube Migration